Application of RIFLE criteria in Chinese patients with ANCA-associated renal vasculitis

Clinical and Experimental Rheumatology

Volumn 29, Issue 6, 2011, Pages 951-957

  Chen, Yong Xi ^a   Zhang, Wen ^a   Chen, Xiao Nong ^a   Shen, Ping Yan ^a   Shi, Hao ^a   Xu, Yao Wen ^a   Ren, Hong ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute kidney injury; AKI; ANCA; Antineutrophil cytoplasmic autoantibody; Chronic kidney disease; CKD; RIFLE; Vasculitis

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHINESE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ACUTE KIDNEY INJURY; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84863232833     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92. (Pubitemid 24065492)
2. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. GUILLEVIN L, DURAND-GASSELIN B, CEV-ALLOS R et al.: Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30. (Pubitemid 29136088)
4. BOOTH AD, ALMOND MK, BURNS A et al.: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84. (Pubitemid 36396745)
5. THADHANI R, PASCUAL M, BONVENTRE JV: Acute renal failure. N Engl J Med 1996;334:1448-60. (Pubitemid 126590563)
6. BOSCH X, GUILABERT A, ESPINOSA G, MI-RAPEIX E: Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007;298:655-69. (Pubitemid 47236417)
7. CHEN YX, YU HJ, ZHANG W et al.: Analyzing fatal cases of Chinese patients with primary antineutrophil cytoplasmic antibodies-associated renal vasculitis: a 10-year retrospective study. Kidney Blood Press Res 2008;31:343-9.
8. BELLOMO R, RONCO C, KELLUM J A, MEHTA RL, PALEVSKY P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
9. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7. (Pubitemid 20273294)
10. MASI AT, HUNDER GG, LIE JT et al.: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100. (Pubitemid 20273293)
11. CHEN YX, YU HJ, NI LY et al.: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 2007;34:2451-6.
12. FALK RJ, JENNETTE JC: ANCA disease: where is this field heading? J Am Soc Nephrol 2010;21:745-52.
13. CHEN M, KALLENBERG CG: New advances in the pathogenesis of ANCA-associated vasculitides. Clin Exp Rheumatol 2009;27:S108-14.
14. GHINOI A, ZUCCOLI G, PIPITONE N, SAL-VARANI C: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature. Clin Exp Rheumatol 2010;28:759-66.
15. ZHANG W, ZHOU G, SHI Q, ZHANG X, ZENG XF, ZHANG FC: Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009;27:S65-9.
16. KAMESH L, HARPER L, SAVAGE CO: ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60. (Pubitemid 34700622)
17. BOSCH X, GUILABERT A, FONT J: Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-18. (Pubitemid 44108124)
18. MEHTA RL, KELLUM JA, SHAH SV et al.: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
19. KELLUM JA, BELLOMO R, RONCO C: Definition and classification of acute kidney injury. Nephron Clin Pract 2008;109:C182-7.
20. KELLUM JA: Acute kidney injury. Crit Care Med 2008;36:S141-5. (Pubitemid 351483043)
21. HARPER L, SAVAGE CO: ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology (Oxford) 2005;44:495-501. (Pubitemid 41511141)
22. LUQMANI RA, BACON PA, MOOTS RJ et al.: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8. (Pubitemid 24334817)
23. FLOSSMANN O, BACON P, DE GROOT K et al.: Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-92. (Pubitemid 46579626)
24. MERKEL PA, CUTHBERTSON DD, HELLMICH B et al.: Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Ann Rheum Dis 2009;68:103-6.
25. CHEN T, DING X, CHEN B: Value of the RIFLE classification for acute kidney injury in diffuse proliferative lupus nephritis. Nephrol Dial Transplant 2009;24:3115-20.
26. CRUZ DN, RICCI Z, RONCO C: Clinical review: RIFLE and AKIN-time for reappraisal. Crit Care 2009;13:211.
27. BAGSHAW SM: Acute kidney injury: diagnosis and classification of AKI: AKIN or RIFLE? Nat Rev Nephrol 2010;6:71-3.
28. BAGSHAW SM, GEORGE C, BELLOMO R: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23:1569-74. (Pubitemid 351767782)
29. PICKERING JW, ENDRE ZH: Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol 2010;5:1165-73.
30. MURRAY PT, DEVARAJAN P, LEVEY as et al.: A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 2008;3:864-8.
31. CHANG CH, LIN CY, TIAN YC et al.: Acute kidney injury classification: comparison of AKIN and RIFLE criteria. Shock 2010;33:247-52.
32. JOANNIDIS M, METNITZ B, BAUER P et al.: Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009;35:1692-702.
33. SRISAWAT N, HOSTE EE, KELLUM JA: Modern classification of acute kidney injury. Blood Purif 2010;29:300-7.
34. VAN BIESEN W, VANHOLDER R, LAMEIRE N: Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol 2006;1:1314-9.
35. ANDERSON RJ, BARRY DW: Clinical and laboratory diagnosis of acute renal failure. Best Pract Res Clin Anaesthesiol 2004;18:1-20. (Pubitemid 38949983)
36. MORGAN DJ, HO KM: A comparison of nonoliguric and oliguric severe acute kidney injury according to the risk injury failure loss end-stage (RIFLE) criteria. Nephron Clin Pract 2010;115: c59-65.
37. MISHRA J, DENT C, TARABISHI R et al.: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-8. (Pubitemid 40469655)
38. YANG HN, BOO CS, KIM MG, JO SK, CHO WY, KIM HK: Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury. Am J Nephrol 2010;31:501-9.
39. HAN WK, BAILLYV, ABICHANDANI R, THAD-HANI R, BONVENTRE JV: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-44. (Pubitemid 34754067)
40. AHLSTROM A, TALLGREN M, PELTONEN S, PETTILA V: Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004;62:344-50. (Pubitemid 39480840)
41. PARIKH CR, JANI A, MELNIKOV VY, FAUBEL S, EDELSTEIN CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-14. (Pubitemid 38298199)
42. PARIKH CR, ABRAHAM E, ANCUKIEWICZ M, EDELSTEIN CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16:3046-52. (Pubitemid 44743502)
43. MURAMATSU Y, TSUJIE M, KOHDA y et al.: Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 2002;62:1601-10. (Pubitemid 35286267)
44. ZAHEDI K, WANG Z, BARONE S et al.: Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003;284:F1046-55. (Pubitemid 36443590)